Back | Next |
home / stock / jagx / jagx message board
Subject | By | Source | When |
---|---|---|---|
Only a 1000 at the moment. Was | timberwolf7 | investorshub | 06/10/2024 4:39:22 PM |
Really, How many do you own? | Pnypnchr | investorshub | 06/10/2024 4:19:27 PM |
Just got notified by Schwab that I can | timberwolf7 | investorshub | 06/10/2024 4:02:01 PM |
Soon like soon, soon or.... imminent? ☠️ | DanDosh | investorshub | 06/10/2024 1:48:24 PM |
Results coming soon!! | oilin07 | investorshub | 06/10/2024 1:30:43 PM |
Jaguar Health Announces New Employee Inducement Grant Under | ShadowDiviner72 | investorshub | 06/08/2024 3:46:49 PM |
Big surprise no results | scho1560 | investorshub | 06/07/2024 10:49:49 PM |
It's a 💩 stock, literally and figuratively... When | DanDosh | investorshub | 06/07/2024 5:55:23 PM |
This stock has OTC stench all over it. | Arcglass | investorshub | 06/07/2024 5:43:18 PM |
Either the shorts are at it right now | timberwolf7 | investorshub | 06/07/2024 3:54:56 PM |
May lows again.. 6 cents.. | timberwolf7 | investorshub | 06/07/2024 3:03:03 PM |
By the time the imminent results are posted | Tom turtles | investorshub | 06/07/2024 2:31:56 PM |
$GME just saved my ass, lol. What a | DanDosh | investorshub | 06/06/2024 11:26:14 PM |
Well... at least it seems like it's found | DanDosh | investorshub | 06/06/2024 8:16:43 PM |
We are passed imminent. She said it | FrostyStar1 | investorshub | 06/06/2024 1:19:25 PM |
Are we passed imminent? The CEO is | FrostyStar1 | investorshub | 06/06/2024 1:18:36 PM |
I know you are not smart, but is | ShadowDiviner72 | investorshub | 06/06/2024 11:50:50 AM |
I like many others are hopeful that redemption | SonicTheHedgeFun | investorshub | 06/06/2024 10:24:24 AM |
Coming this month....ya right. They said the same | Tom turtles | investorshub | 06/06/2024 8:48:08 AM |
The chart won't tell you anything anymore after | ShadowDiviner72 | investorshub | 06/06/2024 8:07:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here ...
New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (...
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific ...